IOV - A NEW START FOR THE PHOENIX

My enquiries earlier in the year revealed that it was IOV's intention to accelerate the reporting of the Prelim Results and publish prior to the Christmas break.

I cannot believe that they have simply missed their deadline.

I therefore conclude that publication has been intentionally delayed either to include the outstanding news re Adept licensing or more likely, because it is their intention to publish them by including them as part of a Circular to Shareholders requesting approval for a corporate transaction.

SkyePharma ?

Consequently I expect news shortly.